Mutations in high-penetrant genes such as BRCA1 (breast cancer 1, early onset) and BRCA2 account for only a small proportion of this hereditary component, suggesting an important but yet-to-be-detected role for low-penetrant single nucleotide polymorphisms. The gene discussed is BRCA2; the disease is breast cancer.